Linda L. Neuman - Chief Medical Officer at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Linda L. Neuman since 13 Jan 2025

Holdings reported by Linda L. Neuman for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,000 $2,243 $0.5608 14 Nov 2022 Direct
Employee Stock Option (right to buy) 550,000 23 Feb 2023 Direct Common Stock

Transactions reported by Linda L. Neuman for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.